Closure of Trading window of the Company from 01.04.2025 till 48 hours after the declaration of Audited financial results for the Quarter and Financial Year ended 31st March, 2025

pdf

Ramky Infrastructure Ltd.

18 Mar 2025

507.95

1.31%

Investor Presentation

Ramky Infrastructure Ltd - 533262 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The company has attended the "Sunidhi Securities Emerging Stars Conference" today.

pdf

Ramky Infrastructure Ltd.

13 Mar 2025

507.95

1.31%

Company Update

Ramky Infrastructure Ltd - 533262 - Announcement On Participating In SUNIDHI SECURITIES EMERGING STARS CONFERENCE

BSE India

We wish to inform that the management would be participating in SUNIDHI SECURITIES EMERGING STARS CONFERENCE scheduled to be held on 18th March 2025

pdf

Ramky Infrastructure Ltd.

06 Mar 2025

507.95

1.31%

Company Update

RAMKY INFRASTRUCTURE LTD. - 533262 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

Intimation under Regulation 30 read with Regulation 37 of SEBI (LODR) Regulations, 2015 regarding scheme of Merger between Sehore Kosmi Tollways Limited (The "Transferor Company-1") and Ramky Elsamex Hyderabad Ring Road Limited (The "Transferor Company-2") (Wholly Owned Subsidiaries) with Ramky Infrastructure Limited ("Transferee Company") Holding Company.

pdf

Ramky Infrastructure Ltd.

24 Feb 2025, 10:37AM

507.95

1.31%

Company Update

RAMKY INFRASTRUCTURE LTD. - 533262 - Outcome Of The Circular Resolution Passed By The Board Of …

BSE India

With reference to the above cited subject, it is hereby informed that the Board of Directors of the company have through circular resolution further deliberated upon the proposal for the extension of the existing Inter-Corporate Deposit (ICD) availed from the Promoter Group for a further tenure, a matter previously discussed in the Board meeting held on 11th February 2025. After due consideration, the Board resolved to defer the postal ballot process for shareholder approval until the necessary consent and confirmation for such extension from the ICD lender is obtained. Upon receipt of such consent and confirmation, the Company shall proceed with seeking shareholder approval for the extension of the ICD. Furthermore, the Board authorized the management to engage in discussions and negotiations with the ICD lender to facilitate the extension of the existing ICD on mutually agreeable terms.

pdf